Evaluation of Immuno-1 toxoplasma IgG assay in the prenatal screening of toxoplasmosis

Lokinendi V. Rao; Olapade A. James; Linda M. Mann; Amin A. Mohammad; Anthony O. Okorodudu; Michael G. Bissell; John R. Petersen

doi:10.1016/S0732-8893(96)00215-5

Evaluation of Immuno-1 toxoplasma IgG assay in the prenatal screening of toxoplasmosis

Lokinendi V. Rao, Olapade A. James, Linda M. Mann, Amin A. Mohammad, Anthony O. Okorodudu, Michael G. Bissell, John R. Petersen

Pathology

Research output: Contribution to journal › Article

2 Scopus citations

Abstract

We evaluated the Immuno-1 (Bayer Diagnostics, Tarrytown, New York, USA) and IMx (Abbott Laboratories, Chicago, Illinois, USA) toxoplasma IgG assays in 298 (223 fresh in-house prenatal + 75 supplied by Bayer) specimens over 15 days. Discordant results were resolved by indirect fluorescence assay (Gull Laboratories, Salt Lake City, Utah, USA). The performance of Immuno-1 assay was found to be comparable to the IMx assay. Immuno-1, being a random access analyzer with minimum hands-on time requirements may have an advantage in the overall laboratory efficiency.

Original language	English (US)
Pages (from-to)	13-15
Number of pages	3
Journal	Diagnostic Microbiology and Infectious Disease
Volume	27
Issue number	1-2
DOIs	https://doi.org/10.1016/S0732-8893(96)00215-5
State	Published - Jan 1 1997

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

Access to Document

10.1016/S0732-8893(96)00215-5

Fingerprint Dive into the research topics of 'Evaluation of Immuno-1 toxoplasma IgG assay in the prenatal screening of toxoplasmosis'. Together they form a unique fingerprint.

Cite this

Rao, L. V., James, O. A., Mann, L. M., Mohammad, A. A., Okorodudu, A. O., Bissell, M. G., & Petersen, J. R. (1997). Evaluation of Immuno-1 toxoplasma IgG assay in the prenatal screening of toxoplasmosis. Diagnostic Microbiology and Infectious Disease, 27(1-2), 13-15. https://doi.org/10.1016/S0732-8893(96)00215-5

@article{065494527e7541d4bea145a2001b0d65,

title = "Evaluation of Immuno-1 toxoplasma IgG assay in the prenatal screening of toxoplasmosis",

abstract = "We evaluated the Immuno-1 (Bayer Diagnostics, Tarrytown, New York, USA) and IMx (Abbott Laboratories, Chicago, Illinois, USA) toxoplasma IgG assays in 298 (223 fresh in-house prenatal + 75 supplied by Bayer) specimens over 15 days. Discordant results were resolved by indirect fluorescence assay (Gull Laboratories, Salt Lake City, Utah, USA). The performance of Immuno-1 assay was found to be comparable to the IMx assay. Immuno-1, being a random access analyzer with minimum hands-on time requirements may have an advantage in the overall laboratory efficiency.",

author = "Rao, {Lokinendi V.} and James, {Olapade A.} and Mann, {Linda M.} and Mohammad, {Amin A.} and Okorodudu, {Anthony O.} and Bissell, {Michael G.} and Petersen, {John R.}",

year = "1997",

month = jan,

day = "1",

doi = "10.1016/S0732-8893(96)00215-5",

language = "English (US)",

volume = "27",

pages = "13--15",

journal = "Diagnostic Microbiology and Infectious Disease",

issn = "0732-8893",

publisher = "Elsevier Inc.",

number = "1-2",

}

TY - JOUR

T1 - Evaluation of Immuno-1 toxoplasma IgG assay in the prenatal screening of toxoplasmosis

AU - Rao, Lokinendi V.

AU - James, Olapade A.

AU - Mann, Linda M.

AU - Mohammad, Amin A.

AU - Okorodudu, Anthony O.

AU - Bissell, Michael G.

AU - Petersen, John R.

PY - 1997/1/1

Y1 - 1997/1/1

N2 - We evaluated the Immuno-1 (Bayer Diagnostics, Tarrytown, New York, USA) and IMx (Abbott Laboratories, Chicago, Illinois, USA) toxoplasma IgG assays in 298 (223 fresh in-house prenatal + 75 supplied by Bayer) specimens over 15 days. Discordant results were resolved by indirect fluorescence assay (Gull Laboratories, Salt Lake City, Utah, USA). The performance of Immuno-1 assay was found to be comparable to the IMx assay. Immuno-1, being a random access analyzer with minimum hands-on time requirements may have an advantage in the overall laboratory efficiency.

AB - We evaluated the Immuno-1 (Bayer Diagnostics, Tarrytown, New York, USA) and IMx (Abbott Laboratories, Chicago, Illinois, USA) toxoplasma IgG assays in 298 (223 fresh in-house prenatal + 75 supplied by Bayer) specimens over 15 days. Discordant results were resolved by indirect fluorescence assay (Gull Laboratories, Salt Lake City, Utah, USA). The performance of Immuno-1 assay was found to be comparable to the IMx assay. Immuno-1, being a random access analyzer with minimum hands-on time requirements may have an advantage in the overall laboratory efficiency.

UR - http://www.scopus.com/inward/record.url?scp=0030891252&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030891252&partnerID=8YFLogxK

U2 - 10.1016/S0732-8893(96)00215-5

DO - 10.1016/S0732-8893(96)00215-5

M3 - Article

C2 - 9127100

AN - SCOPUS:0030891252

VL - 27

SP - 13

EP - 15

JO - Diagnostic Microbiology and Infectious Disease

JF - Diagnostic Microbiology and Infectious Disease

SN - 0732-8893

IS - 1-2

ER -